Abstract
The aims of this study were to analyze the presence of gender differences in the phenotypic expression of schizophrenia at the onset of illness and to explore whether these differences determine clinical and functional outcome 2 years after the initiation of treatment. Data from 231 first-episode-psychosis non-substance-dependent patients (156 men and 75 women) participating in a large-scale naturalistic open-label trial with risperidone were recorded at inclusion and months 1, 6, 12, and 24. Men presented a significant earlier age of onset (24.89 years vs. 29.01 years in women), poorer premorbid functioning, and a higher presence of prodromal and baseline negative symptoms. Women were more frequently married or lived with their partner and children and more frequently presented acute stress during the year previous to onset than men. No other significant clinical or functional differences were detected at baseline. The mean dose of antipsychotic treatment was similar for both genders during the study, and no significant differences in UKU scores were found. The number of hospitalizations was similar between groups, and adherence was more frequent among women. At the 2-year follow-up, both groups obtained significant improvements in outcome measures: PANSS, CGI severity, and GAF scores. Significant gender * time interactions were detected for negative and general PANSS subscales, with the improvement being more pronounced for men. However, no differences were detected for the mean scores obtained during the study in any outcome measure, and the final profile was similar for men and women. Our results suggest that although the initial presentation of schizophrenia can differ according to gender, these differences are not sufficient enough to determine differentiated outcome 2 years after the initiation of treatment in non-substance-dependent patients. The influence of gender on the early course of schizophrenia does not seem to be clinically or functionally decisive in this population.
Similar content being viewed by others
References
Addington D, Addington J, Patten S (1996) Gender and affect in schizophrenia. Can J Psychiatry 41(5):265–268
Aichhorn W, Whitworth AB, Weiss EM, Marksteiner J (2006) Second-generation antipsychotics: is there evidence for sex differences in pharmacokinetic and adverse effect profiles? Drug Saf 29(7):587–598
Alda M, Ahrens B, Lit W, Dvorakova M, Labelle A, Zvolsky P, Jones B (1996) Age of onset in familial and sporadic schizophrenia. Acta Psychiatr Scand 93(6):447–450
Altamura AC, Bassetti R, Bignotti S, Pioli R, Mundo E (2003) Clinical variables related to suicide attempts in schizophrenic patients: a retrospective study. Schizophr Res 60(1):47–55
American Psychiatric Association (1994) A diagnostic and statistical manual of mental disorders, 4 edn. APA, Washington DC
Angermeyer MC, Kuhn L, Goldstein JM (1990) Gender and the course of schizophrenia: differences in treated outcomes. Schizophr Bull 16(2):293–307
Baldessarini RJ, Viguera AC (1995) Neuroleptic withdrawal in schizophrenic patients. Arch Gen Psychiatry 52(3):189–192
Biehl H, Maurer K, Schubart C, Krumm B, Jung E (1986) Prediction of outcome and utilization of medical services in a prospective study of first onset schizophrenics. Results of a prospective 5-year follow-up study. Eur Arch Psychiatry Neurol Sci 236(3):139–147
Brabban A, Tai S, Turkington D (2009) Predictors of outcome in brief cognitive behavior therapy for schizophrenia. Schizophr Bull 35(5):859–864
Cannon-Spoor HE, Potkin SG, Wyatt RJ (1982) Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull 8(3):470–484
Cannon TD, Kaprio J, Lonnqvist J, Huttunen M, Koskenvuo M (1998) The genetic epidemiology of schizophrenia in a Finnish twin cohort. A population-based modeling study. Arch Gen Psychiatry 55(1):67–74
Carrillo JA, Herraiz AG, Ramos SI, Gervasini G, Vizcaino S, Benitez J (2003) Role of the smoking-induced cytochrome P450 (CYP)1A2 and polymorphic CYP2D6 in steady-state concentration of olanzapine. J Clin Psychopharmacol 23(2):119–127
Castle D, Sham P, Murray R (1998) Differences in distribution of ages of onset in males and females with schizophrenia. Schizophr Res 33(3):179–183
Castle DJ, McGrath JA, Kulkarni J (2000) Women and schizophrenia. Cambridge University Press, Cambridge
Castle DJ, Sham PC, Wessely S, Murray RM (1994) The subtyping of schizophrenia in men and women: a latent class analysis. Psychol Med 24(1):41–51
Cotton SM, Lambert M, Schimmelmann BG, Foley DL, Morley KI, McGorry PD, Conus P (2009) Gender differences in premorbid, entry, treatment, and outcome characteristics in a treated epidemiological sample of 661 patients with first episode psychosis. Schizophr Res 114(1–3):17–24
de Leon J, Diaz FJ, Aguilar MC, Jurado D, Gurpegui M (2006) Does smoking reduce akathisia? Testing a narrow version of the self-medication hypothesis. Schizophr Res 86(1–3):256–268
Dervaux A, Laqueille X (2007) Tobacco and schizophrenia: therapeutic aspects. Encephale 33(4 Pt 1):629–632
Endicott J, Spitzer RL, Fleiss JL, Cohen J (1976) The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 33(6):766–771
First M, Spittzer R, Gibbon M, Williams J (1995) Structured clinical interview for DSM-IV axis I disorders, patient ediction (SCID-P, Version 2). N. Y. S. P. Institute, Biometrics Research, New York
Goldstein JM (1988) Gender differences in the course of schizophrenia. Am J Psychiatry 145(6):684–689
Goldstein JM, Link BG (1988) Gender and the expression of schizophrenia. J Psychiatr Res 22(2):141–155
Goldstein JM, Santangelo SL, Simpson JC, Tsuang MT (1990) The role of gender in identifying subtypes of schizophrenia: a latent class analytic approach. Schizophr Bull 16(2):263–275
Gureje O, Bamidele RW (1998) Gender and schizophrenia: association of age at onset with antecedent, clinical and outcome features. Aust N Z J Psychiatry 32(3):415–423
Guy W (1976) Assessment manual for psychopharmacology, Revised edition, ECDEU. US Department of Health, Education and Welfare, Rockville
Hafner H (1998) Onset and course of the first schizophrenic episode. Kaohsiung J Med Sci 14(7):413–431
Hafner H (2003) Gender differences in schizophrenia. Psychoneuroendocrinology. 28(Suppl 2):17–54
Hafner H, an der Heiden W, Behrens S, Gattaz WF, Hambrecht M, Loffler W, Maurer K, Munk-Jorgensen P, Nowotny B, Riecher-Rossler A, Stein A (1998) Causes and consequences of the gender difference in age at onset of schizophrenia. Schizophr Bull 24(1):99–113
Hafner H, Maurer K, Loffler W, Fatkenheuer B, van der Heiden W, Riecher-Rossler A, Behrens S, Gattaz WF (1994) The epidemiology of early schizophrenia. Influence of age and gender on onset and early course. Br J Psychiatry 164(Suppl 23):29–38
Hafner H, Maurer K, Loffler W, Riecher-Rossler A (1993) The influence of age and sex on the onset and early course of schizophrenia. Br J Psychiatry 162:80–86
Hafner H, Riecher-Rossler A, van der Heiden W, Maurer K, Fatkenheuer B, Loffler W (1993) Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia. Psychol Med 23(4):925–940
Hafner H, Riecher A, Maurer K, Loffler W, Munk-Jorgensen P, Stromgren E (1989) How does gender influence age at first hospitalization for schizophrenia? A transnational case register study. Psychol Med 19(4):903–918
Hales R, Yudoofsky S, Talbot J (1999) The american psychiatric press textbook of psychiatry. American Psychiatric Press, Washington DC
Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 6(4):278–296
Iacono WG, Beiser M (1992) Where are the women in first-episode studies of schizophrenia? Schizophr Bull 18(3):471–480
Kelly BD, Feeney L, O’Callaghan E, Browne R, Byrne M, Mulryan N, Scully A, Morris M, Kinsella A, Takei N, McNeil T, Walsh D, Larkin C (2004) Obstetric adversity and age at first presentation with schizophrenia: evidence of a dose-response relationship. Am J Psychiatry 161(5):920–922
Kendler KS, Walsh D (1995) Gender and schizophrenia. Results of an epidemiologically-based family study. Br J Psychiatry 167(2):184–192
Kohler S, van der Werf M, Hart B, Morrison G, McCreadie R, Kirkpatrick B, Verkaaik M, Krabbendam L, Verhey F, van Os J, Allardyce J (2009) Evidence that better outcome of psychosis in women is reversed with increasing age of onset: a population-based 5-year follow-up study. Schizophr Res 113:226–232
Koster A, Lajer M, Lindhardt A, Rosenbaum B (2008) Gender differences in first episode psychosis. Soc Psychiatry Psychiatr Epidemiol 43(12):940–946
Kring AM, Moran EK (2008) Emotional response deficits in schizophrenia: insights from affective science. Schizophr Bull 34(5):819–834
Lambert M, Conus P, Lubman DI, Wade D, Yuen H, Moritz S, Naber D, McGorry PD, Schimmelmann BG (2005) The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis. Acta Psychiatr Scand 112(2):141–148
Larsen TK, Moe LC, Vibe-Hansen L, Johannessen JO (2000) Premorbid functioning versus duration of untreated psychosis in 1 year outcome in first-episode psychosis. Schizophr Res 45(1–2):1–9
Leung A, Chue P (2000) Sex differences in schizophrenia, a review of the literature. Acta Psychiatr Scand Suppl 401:3–38
Lewis SW, Owen MJ, Murray RM (1989) Obstetric complications and schizophrenia: methodology and mechanisms. In: Schulz SC, Tamminga CA (eds) Schizophrenia. A scientific focus. Oxford University Press, New York
Lindstrom E, von Knorring L (1994) Symptoms in schizophrenic syndromes in relation to age, sex, duration of illness and number of previous hospitalizations. Acta Psychiatr Scand 89(4):274–278
Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987) The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl 334:1–100
Maric N, Krabbendam L, Vollebergh W, de Graaf R, van Os J (2003) Sex differences in symptoms of psychosis in a non-selected, general population sample. Schizophr Res 63(1–2):89–95
Mattsson M, Flyckt L, Edman G, Nyman H, Cullberg J, Forsell Y (2007) Gender differences in the prediction of 5-year outcome in first episode psychosis. Int J Methods Psychiatr Res 16(4):208–218
McGlashan TH, Bardenstein KK (1990) Gender differences in affective, schizoaffective, and schizophrenic disorders. Schizophr Bull 16(2):319–329
McGrath JJ (2006) Variations in the incidence of schizophrenia: data versus dogma. Schizophr Bull 32(1):195–197
Moller HJ, Jager M, Riedel M, Obermeier M, Strauss A, Bottlender R (2010) The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: comparison of psychopathological and psychosocial course and outcome and prediction of chronicity. Eur Arch Psychiatry Clin Neurosci 260(5):367–384
Morgan VA, Castle DJ, Jablensky AV (2008) Do women express and experience psychosis differently from men? Epidemiological evidence from the Australian National Study of Low Prevalence (Psychotic) Disorders. Aust N Z J Psychiatry 42(1):74–82
Murray RM, Lewis SW, Reveley AM (1985) Towards an aetiological classification of schizophrenia. Lancet 1(8436):1023–1026
Nicole L, Shiriqui CH (1995) Gender differences in schizophrenia. In: Shiriqui CH, Nasrallah HA (eds) Contemporary issues in the treatment of schizophrenia. American Psychiatric Press, Washington, pp 225–243
Peralta V, Cuesta M (1994) Validación de la escala de los síndromes positivo y negativo (PANSS) en una muestra de esquizofrénicos españoles. Actas Luso- Esp Neurol Psiquiatr 22(4):171–177
Pinals DA, Malhotra AK, Missar CD, Pickar D, Breier A (1996) Lack of gender differences in neuroleptic response in patients with schizophrenia. Schizophr Res 22(3):215–222
Preston NJ, Orr KG, Date R, Nolan L, Castle DJ (2002) Gender differences in premorbid adjustment of patients with first episode psychosis. Schizophr Res 55(3):285–290
Scully PJ, Quinn JF, Morgan MG, Kinsella A, O’Callaghan E, Owens JM, Waddington JL (2002) First-episode schizophrenia, bipolar disorder and other psychoses in a rural Irish catchment area: incidence and gender in the Cavan-Monaghan study at 5 years. Br J Psychiatry Suppl 43:s3–s9
Seeman MV (2000) Women and schizophrenia. Medscape Womens Health 5(2):2
Seeman MV (2004) Gender differences in the prescribing of antipsychotic drugs. Am J Psychiatry 161(8):1324–1333
Seeman MV, Lang M (1990) The role of estrogens in schizophrenia gender differences. Schizophr Bull 16(2):185–194
Szymanski S, Lieberman JA, Alvir JM, Mayerhoff D, Loebel A, Geisler S, Chakos M, Koreen A, Jody D, Kane J et al (1995) Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients. Am J Psychiatry 152(5):698–703
Thorup A, Petersen L, Jeppesen P, Ohlenschlaeger J, Christensen T, Krarup G, Jorgensen P, Nordentoft M (2007) Gender differences in young adults with first-episode schizophrenia spectrum disorders at baseline in the Danish OPUS study. J Nerv Ment Dis 195(5):396–405
Usall J, Haro JM, Ochoa S, Marquez M, Araya S (2002) Influence of gender on social outcome in schizophrenia. Acta Psychiatr Scand 106(5):337–342
Usall J, Ochoa S, Araya S, Gost A, Busquets E (2000) Symptomatology and gender in schizophrenia. Actas Esp Psiquiatr 28(4):219–223
Usall J, Ochoa S, Araya S, Marquez M (2003) Gender differences and outcome in schizophrenia: a 2-year follow-up study in a large community sample. Eur Psychiatry 18(6):282–284
Usall J, Suarez D, Haro JM (2007) Gender differences in response to antipsychotic treatment in outpatients with schizophrenia. Psychiatry Res 153(3):225–231
Verdoux H, Geddes JR, Takei N, Lawrie SM, Bovet P, Eagles JM, Heun R, McCreadie RG, McNeil TF, O’Callaghan E, Stober G, Willinger MU, Wright P, Murray RM (1997) Obstetric complications and age at onset in schizophrenia: an international collaborative meta-analysis of individual patient data. Am J Psychiatry 154(9):1220–1227
Verdoux H, Liraud F, Bergey C, Assens F, Abalan F, van Os J (2001) Is the association between duration of untreated psychosis and outcome confounded? A two year follow-up study of first-admitted patients. Schizophr Res 49(3):231–241
Wechsler D (1974) Wechsler intelligence scale for children-revised manual. Psychological Corporation, New York
Willhite RK, Niendam TA, Bearden CE, Zinberg J, O’Brien MP, Cannon TD (2008) Gender differences in symptoms, functioning and social support in patients at ultra-high risk for developing a psychotic disorder. Schizophr Res 104(1–3):237–245
Young RC, Biggs JT, Ziegler VE, Meyer DA (1978) A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133:429–435
Acknowledgments
This study was sponsored by Janssen-Cilag. The sponsor played no role in the study design, data collection/analysis/interpretation, writing of the report, or the decision to submit the paper for publication. The authors had unlimited access to data. Arantzazu Zabala was supported by the University of the Basque Country UPV/EHU GIU 09/37.
Conflict of interest
Dr Gutierrez has acted as consultant, advisor, or speaker for the following companies: Janssen-Cilag, Lundbeck, and Servier. Dr Eguiluz has acted as consultant, advisor, or speaker for the following companies: AstraZeneca, Bristol-Myers Squibb, Elli Lilly, and Janssen-Cilag. Dr Segarra has acted as consultant, advisor, or speaker for the following companies: Bristol-Myers Squibb, Elli Lilly, and Janssen-Cilag. The other authors have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Segarra, R., Ojeda, N., Zabala, A. et al. Similarities in early course among men and women with a first episode of schizophrenia and schizophreniform disorder. Eur Arch Psychiatry Clin Neurosci 262, 95–105 (2012). https://doi.org/10.1007/s00406-011-0218-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00406-011-0218-2